or Try an Advanced Search...

    Drug Development Stocks List

    Symbol Grade Name % Change
    LDOS A Leidos Holdings, Inc. 0.71
    ITCI A Intra-Cellular Therapies Inc. -1.85
    MNMD B Mind Medicine (MindMed) Inc. 0.24
    SWTX C SpringWorks Therapeutics, Inc. 2.33
    BLTE C Belite Bio, Inc. -0.32
    CERT D Certara, Inc. -1.52
    ONCT D Oncternal Therapeutics, Inc. 2.46
    ALGS D Aligos Therapeutics, Inc. -3.51
    CDXS D Codexis, Inc. -4.46
    NOTV D Inotiv, Inc. -6.85
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
    Related Stock Lists: Biopharmaceutical Pharmacy Alcohol Cancer Clinical Development Clinical Medicine Health Sciences Hepatitis Life Sciences Liver Disease Medicine Non Alcoholic Fatty Liver Disease Pharmaceutical Pharmaceutical Sciences Pharmacology Steatohepatitis Active Pharmaceutical Ingredients Aging Associated Diseases Alzheimer's Disease Antiviral Therapies

    Related ETFs - A few ETFs which own one or more of the above listed Drug Development stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 3.7
    IBRN D iShares Neuroscience and Healthcare ETF 1.2
    LRNZ D TrueMark Technology, AI & Deep Learning ETF 1.16
    IDNA D iShares Genomics Immunology and Healthcare ETF 1.04
    CNCR D Loncar Cancer Immunotherapy ETF 0.88
    View all Drug Development ETFs...
    Compare ETFs
    Compare IBRN to CNCR Compare IBRN to IDNA Compare IBRN to LRNZ

        Drug Development Stocks Recent News

        Date Stock Title
        Apr 25 LDOS Huntington Ingalls (HII) Reports Next Week: Wall Street Expects Earnings Growth
        Apr 25 ITCI Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know
        Apr 25 MNMD MindMed to Present at Upcoming May Medical Conferences
        Apr 24 LDOS Leidos (LDOS) Rises Higher Than Market: Key Facts
        Apr 24 ITCI Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
        Apr 24 SWTX SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 LDOS Leidos (LDOS) to Report Q1 Earnings: What's in the Cards?
        Apr 24 LDOS With 77% ownership in Leidos Holdings, Inc. (NYSE:LDOS), institutional investors have a lot riding on the business
        Apr 24 LDOS Is Most-Watched Stock Leidos Holdings, Inc. (LDOS) Worth Betting on Now?
        Apr 22 ITCI 10 Best Performing Biotech ETFs in 2024
        Apr 22 LDOS Will Lower Commercial Deliveries Hurt Boeing (BA) Q1 Earnings?
        Apr 19 SWTX SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners
        Apr 19 ITCI How Is The Market Feeling About Intra-Cellular Therapies?
        Apr 19 LDOS Wall Street Analysts See Leidos (LDOS) as a Buy: Should You Invest?
        Apr 18 LDOS Leidos (LDOS) Registers a Bigger Fall Than the Market: Important Facts to Note
        Apr 18 CDXS Codexis to Report First Quarter 2024 Financial Results on May 2
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
        Related Stock Lists: Biopharmaceutical Biotechnology Neuroscience Biology Life Sciences Antibodies Artificial Intelligence Cancer Disease Health Sciences Medication Molecular Biology Neurological Disorders Obesity Peptides Acid Advanced Solid Tumors Alzheimer's Disease Amyloidosis Autism Spectrum Disorder
        Drug Development

        Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

        Browse All Tags